These findings suggested that obesity promotes ESCC progression through endocrine mechanisms, with visfatin potentially acting as a mediator by modulating the AMPK-YAP axis, thus contributing to cancer cell survival and tumor progression [54]. The gene discussed is NAMPT; the disease is Obesity.